VP
venBio Partners Portfolio holdings
AUM
$281M
1-Year Est. Return
261.03%
This Fund
S&P 500
1 Year Est. Return
+261.03%
AUM
$281M
AUM Growth
+$64.3M
(+30%)
Holding
6
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$2.11B
| $131M | 46.72% |
4,639,304
|
|
||
|
ALMS
2
Alumis Inc
ALMS
$2.75B
| $99.8M | 35.56% |
4,528,408
-91,395
|
|
||
3
ALX Oncology
ALXO
$256M
| $25.8M | 9.21% |
12,884,638
+3,184,713
|
|
||
4
Harmony Biosciences
HRMY
$1.83B
| $13.7M | 4.88% |
489,194
|
|
||
5
Lyell Immunopharma
LYEL
$404M
| $6.77M | 2.41% |
337,697
|
|
||
|
ARTV
6
Artiva Biotherapeutics
ARTV
$385M
| $3.42M | 1.22% |
531,337
-117,170
|
|